Page 76 - Sohini Das

Abbott's Korea-imported PanBio Covid-19 self test launched at Rs 325

Firm expects demand from both, institutions and retail consumers, will import kits in 4-pack sizes from Korean plant; Test linked with NAVICA app which uploads results on ICMR website

Urge people to use pvt channel vaccine availability: NITI Aayog's V K Paul

Says overall vaccine distribution is done systematically as per availability with manufacturers; 'visibility' on how many doses are expected ahead is shared with state govts

Hetero seeks emergency use authorisation for Merck's antiviral drug

Clinical trial shows molnupiravir helps in early recovery in non-hospitalised Covid-19 patients

Sanofi-GSK Covid-19 vaccine gets nod to start phase-3 trials in India

India part of 35,000 volunteer global efficacy trial

Cabinet reshuffle: Harsh Vardhan fails to clear test ahead of third wave

India's management of the second wave of the Covid-19 pandemic drew all-round criticism both within the country and outside.

4 million doses of Pfizer, Moderna likely through COVAX by August

Indemnity issue to be settled to bring the two US vaccines through COVAX

7.5 mn need 2nd jab in July; we have 4.8 mn doses: Rajasthan minister

In a Q&A, the state's Health Minister Raghu Sharma says Rajasthan has started work to ensure no shortage of medical oxygen during the third Covid-19 wave

Covid-19 cases low but health ministry warns against 'revenge travel'

80% of new cases from 90 districts; N-E states show high case positivity rate

Seven-day average Covid-19 vaccinations at half of June 21 record

Shortage and staggered supplies seem to be playing dampener against ensuring consistent vaccination rates.

80% new Covid cases in India being reported from 90 districts, says govt

Health Ministry cautions against rising travel to tourist spots; 73 districts still reporting over 10% positivity rate; north-eastern states vulnerable

Bharat Biotech-Brazil row: Covaxin nod under controlled conditions

The agency said the suspension - which put the EUA application on ice - was due to missing data from the vaccine's clinical trials

CoWIN goes global: India makes tech open source, 142 nations show interest

This is perhaps the first time any nation is making a software platform developed by its public sector initiative open for the world

Serum Institute may double production of AstraZeneca-Oxford vaccine in 2022

Expect 200-million AstraZeneca vaccine doses next year

Covaxin 77.8% effective against symptomatic Covid-19: Bharat Biotech

The company claimed Covaxin is the first to report promising efficacy against asymptomatic infections based on qPCR testing that will help in reducing disease transmission

NPPA allows 50% price hike for ibuprofen, ranitidine, carbamazepine

These are scheduled drugs (or ones that are under price control) and low priced

Covovax denied trials on children; no nod needed for Sputnik Light

The decision comes as a setback to SII, which had sought permission to start a pediatric clinical trial of Covovax

Haven't received any payment from Brazilian health ministry: Bharat Biotech

Madison Biotech was founded by Krishna Ella in 2020 for external R&D, sales and marketing of vaccines

Cipla gets DCGI nod to import Moderna vaccine; no commercial deal yet

1st mRNA vax part of US-India pact; no commercial deal yet

Serum Institute applies for EU nod through drugmaker AstraZeneca

SII Chief Executive Officer Adar Poonawalla said on Mon­day he had taken it up at the "highest levels".

Moderna vaccine is first mRNA jab to get emergency-use nod in India

Path cleared for importing foreign regulator-approved vaccines without bridging clinical studies; Moderna jab has 94.1% efficacy